GLOBAL AND CHINA OSTEOPOROSIS DRUGS MARKET ANALYSIS

Global and China Osteoporosis Drugs Market, Global and China Osteoporosis Drugs Market, By Drug Type (Bisphosphonates, Alderonate, Risedronate, Ibandronate, Zoledronic Acid, Others, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone-Related Protein (PTHrP) Analog, Rank Ligand (RANKL) Inhibitor), Global and China Osteoporosis Drugs Market (By Route Of Adinistration: Oral, Injectable, Others), Global and China Osteoporosis Drugs Market (By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Sep 2023
Code : CMI4018
Pages :180
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global and China Osteoporosis Drugs Market- Key Players

Major players operating in the global and China osteoporosis drugs market include Merck KGaA, Lilly, Procter & Gamble, Enzo Biochem Inc., Sanofi, Novartis AG, Wyeth Nutrition (A subsidiary of Pfizer Inc.), F. Hoffmann-La Roche Ltd, GSK plc, UCB S.A., Amgen Inc., BeiGene, Inc., Bone Biologics Corp, TEIJIN LIMITED, Eden Biologics (Formerly known as JHL Biotech Inc.), Keros Therapeutics, and Taro Pharmaceutical Industries Ltd.

Global And China Osteoporosis Drugs Market Report Snapshots